Evidence map›Paper›PMID 24743339›Full record

ArticlePLoS pathogens2014

Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.

Peihong Dai, Weiyi Wang, Hua Cao, Francesca Avogadri, Lianpan Dai, Ingo Drexler, Johanna A Joyce, Xiao-Dong Li, Zhijian Chen, Taha Merghoub and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. DNA PAMPs as Molecular Tools for the cGAS-STING Signaling Pathways.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. cGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. Review
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Peihong DaiDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Weiyi WangDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Hua CaoDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Francesca AvogadriImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Lianpan DaiInstitute for Virology, Düsseldorf University Hospital, Heinrich-Heine-University, Düsseldorf, Germany.
Ingo DrexlerInstitute for Virology, Düsseldorf University Hospital, Heinrich-Heine-University, Düsseldorf, Germany.
Johanna A JoyceCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Xiao-Dong LiDepartment of Molecular Biology, University of Texas, Southwestern Medical Center, Dallas, Texas, United States of America.
Zhijian ChenDepartment of Molecular Biology, University of Texas, Southwestern Medical Center, Dallas, Texas, United States of America.
Taha MerghoubImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Stewart ShumanMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Liang DengDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Memorial Sloan Kettering Cancer Center · USThe University of Texas Southwestern Medical Center · USDüsseldorf University Hospital · DEHeinrich Heine University Düsseldorf · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Poxvirus interface with skin immune system, development of anti-poxvirus drugsK08AI073736 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI DENG, LIANG · 2007 to 2010
$537k
Host defense against poxviruses and viral immune evasionR56AI095692 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI DENG, LIANG · 2011 to 2011
$450k
NCI NIH HHS P30 CA008748NIAID NIH HHS K-08 AI073736NIAID NIH HHS K08 AI073736NIAID NIH HHS R56 AI095692NIAID NIH HHS R56AI095692
6 · The paper itself

Abstract

Modified vaccinia virus Ankara (MVA) is an attenuated poxvirus that has been engineered as a vaccine against infectious agents and cancers. Our goal is to understand how MVA modulates innate immunity in dendritic cells (DCs), which can provide insights to vaccine design. In this study, using murine bone marrow-derived dendritic cells, we assessed type I interferon (IFN) gene induction and protein secretion in response to MVA infection. We report that MVA infection elicits the production of type I IFN in murine conventional dendritic cells (cDCs), but not in plasmacytoid dendritic cells (pDCs). Transcription factors IRF3 (IFN regulatory factor 3) and IRF7, and the positive feedback loop mediated by IFNAR1 (IFN alpha/beta receptor 1), are required for the induction. MVA induction of type I IFN is fully dependent on STING (stimulator of IFN genes) and the newly discovered cytosolic DNA sensor cGAS (cyclic guanosine monophosphate-adenosine monophosphate synthase). MVA infection of cDCs triggers phosphorylation of TBK1 (Tank-binding kinase 1) and IRF3, which is abolished in the absence of cGAS and STING. Furthermore, intravenous delivery of MVA induces type I IFN in wild-type mice, but not in mice lacking STING or IRF3. Treatment of cDCs with inhibitors of endosomal and lysosomal acidification or the lysosomal enzyme Cathepsin B attenuated MVA-induced type I IFN production, indicating that lysosomal enzymatic processing of virions is important for MVA sensing. Taken together, our results demonstrate a critical role of the cGAS/STING-mediated cytosolic DNA-sensing pathway for type I IFN induction in cDCs by MVA. We present evidence that vaccinia virulence factors E3 and N1 inhibit the activation of IRF3 and the induction of IFNB gene in MVA-infected cDCs.

Indexed as

AnimalsBone Marrow CellsCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDendritic CellsEndosomesFemaleImmunity, InnateInterferon-betaInterferon Regulatory Factor-3LysosomesMembrane ProteinsMiceMice, KnockoutNucleotidyltransferasesPhosphorylationProtein Serine-Threonine KinasescGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseE3L protein, Vaccinia virusIfnar1 protein, mouseInterferon-betaInterferon Regulatory Factor-3Irf3 protein, mouseMembrane ProteinsNucleotidyltransferasesProtein Serine-Threonine KinasesReceptor, Interferon alpha-betaRNA-Binding ProteinsSting1 protein, mouseSTING ProteinTbk1 protein, mouseViral ProteinsVirulence Factors

Identifiers

PMID24743339
PMCPMC3990710
OpenAlexW1975739500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.